DK0747374T3 - Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer - Google Patents

Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer

Info

Publication number
DK0747374T3
DK0747374T3 DK96109023T DK96109023T DK0747374T3 DK 0747374 T3 DK0747374 T3 DK 0747374T3 DK 96109023 T DK96109023 T DK 96109023T DK 96109023 T DK96109023 T DK 96109023T DK 0747374 T3 DK0747374 T3 DK 0747374T3
Authority
DK
Denmark
Prior art keywords
potassium channel
sulfonamide
channel activators
substituted benzopyrans
benzopyrans
Prior art date
Application number
DK96109023T
Other languages
Danish (da)
English (en)
Inventor
Karnail S Atwal
Charles Z Ding
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0747374T3 publication Critical patent/DK0747374T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
DK96109023T 1995-06-07 1996-06-05 Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer DK0747374T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,007 US5869478A (en) 1995-06-07 1995-06-07 Sulfonamido substituted benzopyran derivatives

Publications (1)

Publication Number Publication Date
DK0747374T3 true DK0747374T3 (da) 2002-04-08

Family

ID=23910215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96109023T DK0747374T3 (da) 1995-06-07 1996-06-05 Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer

Country Status (10)

Country Link
US (1) US5869478A (de)
EP (1) EP0747374B1 (de)
JP (1) JP3926868B2 (de)
AT (1) ATE210650T1 (de)
AU (1) AU714432B2 (de)
CA (1) CA2178353A1 (de)
DE (1) DE69617803T2 (de)
DK (1) DK0747374T3 (de)
ES (1) ES2169174T3 (de)
PT (1) PT747374E (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077850A (en) 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
FR2807045B1 (fr) 2000-03-31 2004-02-27 Atofina Copolymeres acryliques hydrosolubles et leur utilisation comme fluidifiants ou dispersants
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
KR100492252B1 (ko) * 2002-08-09 2005-05-30 한국화학연구원 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법
EP1589015A1 (de) * 2004-02-03 2005-10-26 Université de Liège Benzopyranderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
KR100823805B1 (ko) * 2004-05-05 2008-04-21 에프. 호프만-라 로슈 아게 5-ht6 수용체, 5-ht2a 수용체 또는 둘다를 조절하기에유용한 아릴설포닐 벤조다이옥산
EP1831203A1 (de) 2004-12-21 2007-09-12 F. Hoffmann-Roche AG Chromanderivate und deren anwendungen bei der behandlung von zns-erkrankungen
ATE448216T1 (de) * 2004-12-21 2009-11-15 Hoffmann La Roche Tetralin- und indanderivate und anwendungen davon
MX2007007482A (es) * 2004-12-21 2007-07-20 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos como antagonistas de 5-ht.
CA2592001A1 (en) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-ht receptor ligands
MX2007007558A (es) * 2004-12-21 2007-07-24 Hoffmann La Roche Derivados de tetralina y de indano y usos de los mismos.
US20070026079A1 (en) * 2005-02-14 2007-02-01 Louis Herlands Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels
CN1854135B (zh) * 2005-04-18 2013-06-12 李伟章 由氰基胍连接组成的杂环化合物及其医药应用
EP2671507A3 (de) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-Informatiksystem
KR20080015102A (ko) 2005-05-10 2008-02-18 버텍스 파마슈티칼스 인코포레이티드 이온 채널 조절인자로서의 바이사이클릭 유도체
ATE527251T1 (de) * 2005-05-16 2011-10-15 Vertex Pharma Bicyclische derivate als modulatoren von ionenkanälen
WO2007042906A1 (en) 2005-10-07 2007-04-19 Glenmark Pharmaceuticals S.A. Substituted benzofused derivatives and their use as vanilloid receptor ligands
BRPI0618206A2 (pt) * 2005-11-03 2011-08-23 Hoffmann La Roche arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos
US8067607B2 (en) * 2006-02-01 2011-11-29 Merck Sharp & Dohme Corp. Potassium channel inhibitors
CA2654822A1 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
BRPI0713502A2 (pt) * 2006-06-20 2012-03-13 F. Hoffmann-La Roche Ag derivados de tetralina de arilsulfonamidil e empregos destes
CN101472884A (zh) * 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其用途
EP1884515A1 (de) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituierte Indanylsulfonamid-Verbindungen, ihre Herstellung und Verwendung als Medikament
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN106243023A (zh) 2010-09-03 2016-12-21 福马Tm有限责任公司 用于抑制nampt的胍化合物和组合物
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
KR102484846B1 (ko) * 2015-11-27 2023-01-05 한림제약(주) 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법
WO2018134265A1 (en) 2017-01-17 2018-07-26 Forrest Michael David Therapeutic inhibitors of the reverse mode of atp synthase
WO2019012149A1 (en) 2017-07-13 2019-01-17 Forrest Michael David THERAPEUTIC MODULATORS OF THE INVERSE MODE OF ATP SYNTHASE

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004468A (en) * 1963-08-21 1965-09-15 Pfizer Ltd Chroman derivatives
US3812157A (en) * 1972-03-31 1974-05-21 Ncr Benzopyran compounds
US3953506A (en) * 1974-02-07 1976-04-27 American Cyanamid Company Ureidotetralin compounds
US4391815A (en) * 1976-04-02 1983-07-05 Beecham Group Limited Cyanobenzano[b]pyrans
NZ183551A (en) * 1976-04-02 1978-09-20 Beecham Group Ltd Aminochromanols and pharmaceutical compositions containingthem
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4428881A (en) * 1977-12-23 1984-01-31 Gulf Oil Corporation Control of unwanted vegetation with N-carbamylindolines
EP0028064B1 (de) * 1979-09-28 1983-07-20 Beecham Group Plc Chromanol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung
DE3064285D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
EP0046652B1 (de) * 1980-08-21 1985-05-22 Beecham Group Plc Chromanol-Derivate, ihre Herstellung und diese enthaltende Arzneimittel
EP0076075B1 (de) * 1981-09-25 1986-11-20 Beecham Group Plc Benzopyran-Verbindungen mit pharmazeutischer Wirkung
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
DE3368629D1 (en) * 1982-04-28 1987-02-05 Beecham Group Plc Novel chromenes and chromans
EP0095316B1 (de) * 1982-05-21 1986-12-03 Beecham Group Plc Pharmazeutisch wirksame Aminobenzopyrane
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
DE3486354T2 (de) * 1983-05-18 1995-03-30 Beecham Group Plc Chroman- und Chromenderivate.
EP0139992B1 (de) * 1983-09-01 1988-12-28 Beecham Group Plc Chromanol-Derivate
DE3411993A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
DE3682331D1 (de) * 1985-06-08 1991-12-12 Beecham Group Plc Pyrano(3,2-c)pyridinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
GB8521857D0 (en) * 1985-09-03 1985-10-09 Beecham Group Plc Active compounds
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
US5210234A (en) * 1986-05-03 1993-05-11 Beecham Group P.L.C. Benzopyran intermediates
GB8613786D0 (en) * 1986-06-06 1986-07-09 Beecham Group Plc Active compounds
GB8625185D0 (en) * 1986-10-21 1986-11-26 Beecham Group Plc Active compounds
US4734421A (en) * 1986-10-29 1988-03-29 Merck & Co., Inc. Anti-inflammatory substituted 2-benzyl-mercapto-imidazole and pyrimidine derivatives compositions and method of use therefor
GB8806990D0 (en) * 1988-03-23 1988-04-27 Beecham Group Plc Novel compounds
DE3852145T2 (de) * 1987-02-18 1995-04-06 Beecham Group Plc Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten.
CH674984A5 (de) * 1987-05-16 1990-08-15 Sandoz Ag
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
US5310750A (en) * 1987-10-19 1994-05-10 Beecham Group P.L.C. Heterocyclic compounds useful as α2 -adrenoceptor antagonists
CA1308108C (en) * 1987-10-27 1992-09-29 Dominick A. Quagliato Antihypertensive benzopyran derivatives
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US4988723A (en) * 1988-06-02 1991-01-29 Fujisawa Pharmaceutical Co., Ltd. Benzopyran derivatives and their use as anti-hypertensives
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate
CA1336963C (en) * 1988-07-18 1995-09-12 Gary James Grover Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
ATE139775T1 (de) * 1988-09-16 1996-07-15 Beecham Group Plc Benzopyranderivate mit einer blutdrucksenkenden wirkung
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US4997846A (en) * 1988-12-09 1991-03-05 Researche Syntex France, S.A. Novel benzopyranylpyrrolinone derivatives
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds
GB8902118D0 (en) * 1989-02-01 1989-03-22 Beecham Group Plc Chemical process
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
CA2015296C (en) * 1989-05-31 2001-08-07 Karnail Atwal Pyranyl cyanoguanidine derivatives
DE3919365A1 (de) * 1989-06-14 1990-12-20 Bayer Ag 2-acylamino-4-halogen-5-nitrothiazol-derivate, verfahren zu ihrer herstellung, ihre verwendung in schaedlingsbekaempfungsmitteln und neue zwischenprodukte
CA2020437A1 (en) * 1989-07-05 1991-01-06 Yoshihide Fuse Cinnamamide derivative
HU207861B (en) * 1989-07-21 1993-06-28 Alkaloida Vegyeszeti Gyar Process for producing benzopirane derivative of blood pressure lowering activity
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
JPH0366669A (ja) * 1989-08-03 1991-03-22 Shionogi & Co Ltd 複素環式化合物
US5095016A (en) * 1989-08-11 1992-03-10 Kaken Pharmaceutical Co., Ltd. Benzopyran compounds, processes for their production and pharmaceutical compositions
US4983612A (en) * 1989-10-05 1991-01-08 American Home Products Corporation Antihypertensive benzopyran derivatives
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
GB8924376D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
WO1991009031A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Trifluoromethyl substituted compounds and a pharmaceutical composition
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
US5276168A (en) * 1990-06-18 1994-01-04 E. R. Squibb & Sons, Inc. Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
AU651105B2 (en) * 1990-06-18 1994-07-14 E.R. Squibb & Sons, Inc. Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
DK0471515T3 (da) * 1990-08-15 1997-07-21 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
GB9020927D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
DE4038752A1 (de) * 1990-12-05 1992-06-11 Merck Patent Gmbh Chromanderivate
GB9103839D0 (en) * 1991-02-23 1991-04-10 Smithkline Beecham Plc Pharmaceuticals
US5310932A (en) * 1991-04-15 1994-05-10 E. R. Squibb & Sons, Inc. Chromanyl substituted indole potassium channel openers
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
CA2074864A1 (en) * 1991-07-30 1993-01-31 Carmen Almansa Tetralones with pharmacological activity
JP3502403B2 (ja) * 1991-12-16 2004-03-02 アベンティス ファーマ株式会社 骨吸収抑制剤
US5374643A (en) * 1992-09-11 1994-12-20 E. R. Squibb & Sons, Inc. Aryl urea (thiourea) and cyanoguanidine derivatives
US5393771A (en) * 1993-05-12 1995-02-28 Brisol-Myers Squibb Company 4-substituted benzopyran and related compounds
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds

Also Published As

Publication number Publication date
DE69617803D1 (de) 2002-01-24
EP0747374A1 (de) 1996-12-11
ES2169174T3 (es) 2002-07-01
AU714432B2 (en) 2000-01-06
CA2178353A1 (en) 1996-12-08
JPH093035A (ja) 1997-01-07
PT747374E (pt) 2002-05-31
AU5476296A (en) 1996-12-19
EP0747374B1 (de) 2001-12-12
US5869478A (en) 1999-02-09
JP3926868B2 (ja) 2007-06-06
DE69617803T2 (de) 2002-08-01
ATE210650T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
DK0747374T3 (da) Sulfonamidsubstituerede benzopyraner som kaliumkanalaktivatorer
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
ES2088537T3 (es) Derivados de piranil cianoguanidina.
NO902394L (no) Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
AU591860B2 (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
PT1043310E (pt) Derivados de bifenilamidina
ATE73795T1 (de) Thioformamid-derivate.
DK0389162T3 (da) 2,5,6,7-Tetranor-4,8-inter-m-phenylen PGI2 derivater
EP0995437A4 (de) 2,3-dihydrobenzofuran derivate
DE69410198D1 (de) Cyclohexanderivate als Kaliumkanalaktivatoren
ATE176242T1 (de) Uck14-verbindungen
DE69014256D1 (de) Benzopyran-Derivate.
FI933928A0 (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel